Trial NCT02642094

View at ClinicalTrials.gov 
Org. Study IDs: CTMS 15-2096
Secondary IDs: 1R01CA192564-01A1

Last trial update was posted on 2023-12-05

MeSH Interventions

Sirolimus

MeSH Conditions

Breast Neoplasms

Other Conditions

Cancer of Breast

Stopping Reasons

The study was terminated early according to the protocol due to efficacy.

Limitations And Caveats

Our hypothesis was that a low dose and short term treatment with rapamycin in patients with early stage breast cancer would show significantly attenuation of mammary stem and progenitor cell activity and tumor progression biomarkers in a non-randomized study.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID